Regenerative medicine

TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

Retrieved on:

Thursday, March 21, 2024

Dopamine, Congress, Parkinson's disease, Regenerative medicine, Transplant, Tree, Patient, Disease, Cell therapy, Society, Neuron, Therapy, Cell, IPSC, Neurodegenerative disease, Pharmaceutical industry

BORDEAUX, France, March 21, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is today presenting their latest data in Parkinson's Disease, at the 23rd Congress of the Japanese Society for Regenerative Medicine, in Niigata, Japan.

Key Points:

Parkinson's Disease is the second most common neurodegenerative disease, caused by the progressive loss of neurons in the midbrain and other brain regions.
Affecting 10 million people worldwide, it is a debilitating disease and there is an urgent unmet need as only symptomatic treatment is currently available.
Symptoms usually appear when between 60-80% of dopaminergic neurons are already lost, so a regenerative medicine approach that can replace these neurons holds great potential.
The microtissue format has many benefits, including better reproducibility and a better-quality control as batch release is based on mechanism of action relevant dopamine quantification" explains Maxime Feyeux, Chief Scientific Officer, TreeFrog Therapeutics.

TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

Retrieved on:

Thursday, March 21, 2024

BORDEAUX, France, March 21, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is today presenting their latest data in Parkinson's Disease, at the 23rd Congress of the Japanese Society for Regenerative Medicine, in Niigata, Japan.

Key Points:

Parkinson's Disease is the second most common neurodegenerative disease, caused by the progressive loss of neurons in the midbrain and other brain regions.
Affecting 10 million people worldwide, it is a debilitating disease and there is an urgent unmet need as only symptomatic treatment is currently available.
Symptoms usually appear when between 60-80% of dopaminergic neurons are already lost, so a regenerative medicine approach that can replace these neurons holds great potential.
The microtissue format has many benefits, including better reproducibility and a better-quality control as batch release is based on mechanism of action relevant dopamine quantification" explains Maxime Feyeux, Chief Scientific Officer, TreeFrog Therapeutics.

Tempo Therapeutics Secures Series A Financing to Advance Cutting-Edge Tissue Scaffold Products into Clinical Trials

Retrieved on:

Tuesday, March 19, 2024

Tissue engineering, Attention, Growth, SAN, Fascia, Tempo, Human, MAP, Regenerative medicine, Therapy, Safety, Innovation system

The funding will propel Tempo forward as it advances its revolutionary Microporous-Annealed-Particle (MAP) technology platform and takes its synthetic tissue scaffold candidates into clinical trials.

Key Points:

The funding will propel Tempo forward as it advances its revolutionary Microporous-Annealed-Particle (MAP) technology platform and takes its synthetic tissue scaffold candidates into clinical trials.
In conjunction with the financing, Steven Sands of Galaxy Partners and a representative from JJDC will join the board.
With this financing, Tempo is entering into the first ever clinical trials of surgical scaffolds based on MAP technology.
"At Tempo Therapeutics, we are driven by a commitment to innovation and excellence in the field of regenerative medicine," said Westbrook Weaver, Founder and CEO of Tempo Therapeutics.

GBK Brand Bar Celebrated their 15th Annual Luxury Lounge prior to Oscars, Presented by Care A2+

Retrieved on:

Tuesday, March 12, 2024

BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+. GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways. As always, there was an amazing selection of beverages & food to nibble on, as well as music from DJ Kara keeping the guests entertained from the moment they entered.

Key Points:

BEVERLY HILLS, Calif., March 12, 2024 /PRNewswire/ -- The Biggest Award night in Hollywood, brought out the brightest stars in Entertainment for GBK Brand Bar's 15th Annual Oscar Luxury Lounge at the Beverly Wilshire Hotel, Presented by CARE A2+.
GBK Brand Bar presented select guests over $100,000 in various gifts, including 7 different travel getaways, (African Safari, Turks & Caicos, Greece, and many others) Electronics, Jewelry, and 20 other exciting giveaways.
Care A2+ donated product to a local women's shelter in the name of the celebrities present.
Any media inquiries and/or interview request, please contact Tad Hamilton of Mosaic Public Relations at: [email protected]
This press release was issued through 24-7PressRelease.com.

Deputy Minister of Ukraine, Nataliia Kalmykova, will be speaking at the LA Convention Center this week

Retrieved on:

Tuesday, March 12, 2024

Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.

Key Points:

Deputy Minister of Ukraine, Nataliia Kalmykova, will be amongst keynotes ; Ukrainian neurosurgeons from the frontline will also be speaking about combat casualty care and participate in the convention in person.
Since the beginning of the war in Ukraine, SBMT has been supporting Ukrainian doctors with training and medical equipment.
The SBMT World Congress is renowned for its comprehensive program, offering a diverse range of presentations, hands-on workshops, Bioskills cadaver labs, and an expansive exhibition hall.
Attendees can expect to engage with cutting-edge research, innovative technologies, and expert insights that are shaping the future of neurosciences and neurotechnology.

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

Retrieved on:

Monday, March 11, 2024

Flex, Regenerative medicine, Integra, Global marketing, Surgeon, UBM, Development, Research, Management

PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.

Key Points:

PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.
“MicroMatrix Flex has allowed me to expand how I use UBM technology in complex wound reconstruction procedures,” said Dr. Aaron Moore, acute care surgeon, Mercy Health - St. Vincent Medical Center.
During this period, UBM has been published in more than 200 pre-clinical and clinical publications.
“We’re excited to be adding MicroMatrix Flex to our market-leading portfolio of dermal matrices,” commented Steve Powick, senior vice president, Global Marketing, Tissue Technologies Product Division.

Orthogonal Global Group Announces the Appointment of Mona Coyle to the Board of Directors

Retrieved on:

Thursday, March 7, 2024

Blockchain, Regenerative medicine, ICU, AI, Orthogonality, KZ2, Health, OTC Markets Group, Entrepreneurship, Longevity, Medicine

Mrs. Coyle is a Registered Nurse with over a decade of ICU and clinical operations experience.

Key Points:

Mrs. Coyle is a Registered Nurse with over a decade of ICU and clinical operations experience.
She has more than 20 years in management and business development, including extensive experience in influencing strategic directions in healthcare.
“We are excited to have Mrs. Coyle as the new independent director on the Company’s board of directors.
The appointment of Mrs. Coyle follows the resignation of Mr. Mike Grantis from the Board, effective immediately.

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

Retrieved on:

Wednesday, March 6, 2024

HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global wellbeing and sustainability, today announced the appointment of attorney James Roosevelt, Jr. to the Company’s Advisory Board.

Key Points:

HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote global wellbeing and sustainability, today announced the appointment of attorney James Roosevelt, Jr. to the Company’s Advisory Board.
The intersection of public policy and health is a passion for him.
As CEO of Tufts Health Plan, his leadership achieved consistent profitability while attaining the #1 ranking from the National Committee for Quality Assurance.
Mr. Roosevelt is also a trustee of the Cambridge Public Library, the Cambridge Community Foundation, and the Atrius Health Equity Foundation.

The World Wellness Show, LLC Expands Groundbreaking Educational Health and Wellness TV Show to 137 Countries to Catalyze Global Paradigm Shift

Retrieved on:

Tuesday, March 5, 2024

Medicine, Sleep, Mental health, COVID-19, Regenerative medicine, Education, Nursing

The show is broadcast free in 137 countries, offering viewers a wealth of educational content to inspire a shift from traditional sick care to a focus on holistic well care.

Key Points:

The show is broadcast free in 137 countries, offering viewers a wealth of educational content to inspire a shift from traditional sick care to a focus on holistic well care.
Doctors can now effectively promote their passion of holistic wellness messages worldwide.
In a world where the importance of well-being is increasingly recognized, as we, the global community, take charge of ensuring this message reaches far and wide.
(1) Education can help viewers self-discover the transformative power of a proactive approach to wellness.

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Retrieved on:

Monday, March 4, 2024

Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.

Key Points:

Osteoarthritis of the knee is a debilitating disease affecting Singapore’s aging population and the clinical trial will pioneer stem cell use for regenerative medicine in Singapore.
UC-MSCs are a type of adult stem cells that can be isolated from the umbilical cord tissue after childbirth.
UC-MSCs are considered multipotent and are able to differentiate into different cell types, including bone, cartilage, fat, and muscle cells.
"Our collaboration with CytoMed marks a significant step in advancing research on allogeneic in-vivo UC-MSC for cartilage repair, including osteoarthritis of the knee.